Syngenta Group Ventures — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data.
AI & Machine LearningBiotechHealthtechDurham, US
John A. Ryals(Executive Officer, Director)inGerald M. Haines II(Executive Officer)Rohan F. Hastie(Executive Officer, Director)in
BoardJohn Oxaal(Director)R. Scott Barry(Director)R. John Fletcher(Director)
Board seatDavid Pierson· per SEC Form D · $48M raise · filed Sep 2020
Co-investorsCamden PartnersEssex Woodlands Healthcare PartnersHavencrest Capital ManagementRevelation Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.